You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment-Naïve

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Fort Myers, Saint Petersburg, Nashville (Ublituximab, Umbralisib)

Terminated
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Fort Myers, Florida
  • +2 more
Jul 20, 2022

Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)

Completed
  • Chronic Hepatitis B
  • NCO-48 Fumarate 4 mg
  • +2 more
  • Monterey Park, California
    National Institute of Clinical Research, Inc
Jan 3, 2023

Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

Recruiting
  • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
  • Olverembatinib plus venetoclax and dexamethasone
  • Xi'an, Shannxi, China
    Department of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023

Chronic Lymphocytic Leukemia Trial in Milano (Ibrutinib and obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Ibrutinib and obinutuzumab
  • Milano, MI, Italy
    Strategic Research Program on CLL
Apr 2, 2022

Age Related Macular Degeneration Trial in Indianapolis (RBM-007 Injectable Solution)

Recruiting
  • Age Related Macular Degeneration
  • RBM-007 Injectable Solution
  • Indianapolis, Indiana
    Midwest Eye Institute
Feb 10, 2022

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Diabetes Trial in Singapore (Dapagliflozin, MetFORMIN 500 Mg Oral Tablet, Dapagliflozin / metFORMIN Pill)

Recruiting
  • Diabetes
  • Singapore, Singapore
    Tan Tock Seng Hospital
Jun 29, 2022

Chronic Hepatitis b Trial in Chongqing, Xi'an (Placebo, TQA3605 tablets, Entecavir dispersible tablets)

Recruiting
  • Chronic Hepatitis b
  • Placebo
  • +4 more
  • Chongqing, Chongqing, China
  • +2 more
Nov 27, 2023

HIV-1-infection Trial in Liuzhou, Najing, Tianjin (B/F/TAF, TDF/3TC/EFV)

Recruiting
  • HIV-1-infection
  • Liuzhou, Guangxi, China
  • +2 more
Mar 31, 2022

Lung Cancer Metastatic Trial in Durham (Nivolumab, Ipilimumab, Evolocumab)

Recruiting
  • Lung Cancer Metastatic
  • Durham, North Carolina
    Duke Univ. Medical Center
May 16, 2022

Liposarcoma, Dedifferentiated Trial (Brigimadlin)

Not yet recruiting
  • Liposarcoma, Dedifferentiated
  • (no location specified)
Sep 22, 2023

Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)

Active, not recruiting
Has Results
  • Melanoma
  • FDG PET/CT scan
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Jan 10, 2023

Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Jinan, China
  • +2 more
Sep 10, 2023

Idiopathic Pulmonary Fibrosis Trial in London (LTI-03, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • London, United Kingdom
    Study Site
Jul 18, 2023

Human Immunodeficiency Virus (HIV) Trial (Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo)

Active, not recruiting
Has Results
  • Human Immunodeficiency Virus (HIV)
  • Doravirine, Tenofovir, Lamivudine
  • +2 more
  • (no location specified)
Sep 1, 2022

Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 6, 2023

Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

Not yet recruiting
  • Exudative Age Related Macular Degeneration
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Nov 28, 2022

Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • (no location specified)
Jul 10, 2023

Chronic Lymphocytic Leukemia (CLL) Trial (Venetoclax, Rituximab, Ibrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • (no location specified)
Apr 2, 2022

Melanoma, Uveal Trial in Portland (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma, Uveal
  • Portland, Oregon
    Providence Portland Medical Center
Aug 2, 2022

Chronic Pulmonary Aspergillosis Trial in Chandigarh (Itraconazole 200 mg, Voriconazole 200mg)

Recruiting
  • Chronic Pulmonary Aspergillosis
  • Itraconazole 200 mg
  • Voriconazole 200mg
  • Chandigarh, India
  • +1 more
Jun 10, 2022

Fabry Disease Trial in Australia, Brazil, United States (AVR-RD-01)

Terminated
  • Fabry Disease
  • Hackensack, New Jersey
  • +4 more
Nov 15, 2022

Acute Myeloid Leukemia Trial in Sacramento (Azacitidine, Uproleselan, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 12, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Diabetic Retinopathy, Macular Edema Trial in Montemorelos (PPV/MP, Intravitreal injection)

Completed
  • Diabetic Retinopathy
  • Macular Edema
  • PPV/MP
  • Intravitreal injection
  • Montemorelos, Nuevo Leon, Mexico
    Hospital La Carlota
Nov 20, 2021